Fidalab/ Briway Seattle is a privately owned CLIA-certified clinical diagnostic company in Seattle, WA, specializing in nucleic acid-based molecular testing. The name “Fida” comes from latin meaning faithful, loyal. and trusting.
Our mission is to improve people’s lives by assisting healthcare providers to achieve accurate and timely diagnosis and by identifying at risk individuals for various diseases for closer surveillance, prevention, and early intervention with our tests, which employ cutting edge technologies.
CO- FOUNDER - BRIWAY SEATTLE / FIDALAB
Dr. Qinghua (Quinne) Feng received her PhD in Molecular Biology/ Genetics from The John Hopkins University School of Medicine and did her Postdoctoral Fellow at Whitehead Institute/MIT. She worked at the University of Washington for 15 years as a research scientist and faculty member in the Department of Pathology. Dr. Feng has more than 90 peer-reviewed scientific publications and 5 book chapters, and received research funding from the National Institute of Health. She is one of the co-founders at Fidalab/ Briway Seattle and developed an accurate and sensitive screening assay for oral HPV 16 and 18 as well as a periodontal pathogen test. Dr. Feng remains a dedicated research scientist and is passionate about science and how it can improve life and health.